KIMMEL, G.; CHIMA, M.; KIM, H. J.; BARES, J.; YAROSHINSKY, A.; SINGER, G.; KIM, S. J.; BAGEL, J.; LEBWOHL, M. Brodalumab in the treatment of moderate-to-severe psoriasis in patients refractory to anti-interleukin-17A therapies: Evaluation of secondary endpoints. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 5, n. 5, p. 524–529, 2021. DOI: 10.25251/skin.5.5.10. Disponível em: https://jofskin.org/index.php/skin/article/view/1309. Acesso em: 19 oct. 2021.